Samuel Jefroykin 🎗️
About Samuel Jefroykin 🎗️
Samuel Jefroykin serves as the Director of Data & Research at Eleos Health, where he leads a multidisciplinary team to enhance clinical decision-making through AI. With a background in data science and analytics, he has held various roles in notable organizations, including Zencity and Motorola Solutions.
Current Role at Eleos Health
Samuel Jefroykin serves as the Director of Data & Research at Eleos Health, a position he has held since 2023. In this role, he is responsible for developing and executing data-driven initiatives that enhance clinical decision-making. He oversees a multidisciplinary team that includes researchers, data scientists, data engineers, data analysts, and clinical analysts. Jefroykin advocates for the use of AI as a tool to augment human clinicians, emphasizing the importance of human intelligence combined with AI capabilities.
Previous Experience in Data Science
Before his current role, Samuel Jefroykin held various positions in the data science field. He worked at Zencity as a Senior Data Scientist from 2018 to 2019 and previously as a Data Scientist from 2017 to 2018. His experience also includes a Data Scientist Internship at Skai in 2016 and a Data Analysis & IT Internship at Bansard International in Shanghai from 2015 to 2016. Additionally, he served as a Data Scientist Student at Motorola Solutions for one month in 2017.
Educational Background
Samuel Jefroykin has a solid educational foundation in mathematics and data science. He studied at Université Paris Dauphine - PSL, where he earned a Licence in Applied Mathematics from 2012 to 2014. He then attended the University of Helsinki, focusing on Mathematics and Statistics, achieving an M1 MIDO STM (Stat) from 2014 to 2015. He further enhanced his skills at Israel Tech Challenge, completing a Data Science & Cyber Security trainee program from 2016 to 2017.
Leadership at Eleos Health
In addition to his current role, Samuel Jefroykin previously served as the Data Science Team Lead at Eleos Health from 2021 to 2023. In this capacity, he fostered growth and guided a talented team towards achieving meaningful impacts in the healthcare sector. His leadership emphasized the integration of augmented intelligence to enhance human capabilities in clinical settings, focusing on training AI models with real-world session data.